IM2 Regimen Is Effective and Safe for Relapsed or Refractory T-Cell Lymphoblastic Lymphoma/Leukemia
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-200749
Abstract: Patients with refractory or relapsed (R/R) T-cell lymphoblastic lymphoma/leukemia (T-LBL/ALL) typically exhibit poor responses to salvage chemotherapy, leading to a dismal prognosis. IM2 as a novel salvage regimen for R/R T-LBL/ALL, which is composed of… read more here.
Keywords: lymphoblastic lymphoma; im2 regimen; effective safe; cell ... See more keywords